Skip to content

Opening book details…

About this Medicine article

718P A phase II study of patients with advanced or metastatic renal cell carcinoma (mRCC) receiving pazopanib after previous checkpoint inhibitor treatment by T.B. Powles; S. Oudard; V. Grünwald; E. Calvo; M.D. Michaelson; M. Burotto; B. Melichar; R. Tyagi; F. Hilmi; A. Gaur; Y. Hirschberg; D. Heng is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
T.B. Powles; S. Oudard; V. Grünwald; E. Calvo; M.D. Michaelson; M. Burotto; B. Melichar; R. Tyagi; F. Hilmi; A. Gaur; Y. Hirschberg; D. Heng
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
2020
Language
EN
Field
Medicine (Health Sciences)

More by T.B. Powles; S. Oudard; V. Grünwald; E. Calvo; M.D. Michaelson; M. Burotto; B. Melichar; R. Tyagi; F. Hilmi; A. Gaur; Y. Hirschberg; D. Heng

Browse all works by T.B. Powles; S. Oudard; V. Grünwald; E. Calvo; M.D. Michaelson; M. Burotto; B. Melichar; R. Tyagi; F. Hilmi; A. Gaur; Y. Hirschberg; D. Heng